Literature DB >> 33536170

Nonsegmented Negative-Sense RNA Viruses Utilize N 6-Methyladenosine (m6A) as a Common Strategy To Evade Host Innate Immunity.

Mijia Lu1, Miaoge Xue1, Hai-Tao Wang2,3, Elizabeth L Kairis1, Sadeem Ahmad2,3, Jiangbo Wei4,5,6, Zijie Zhang4,5,6, Qinzhe Liu4,5,6, Yuexiu Zhang1, Youling Gao1, Dominique Garcin7, Mark E Peeples8,9, Amit Sharma1,10, Sun Hur2,3, Chuan He4,5,6,11, Jianrong Li12.   

Abstract

N 6-Methyladenosine (m6A) is the most abundant internal RNA modification catalyzed by host RNA methyltransferases. As obligate intracellular parasites, many viruses acquire m6A methylation in their RNAs. However, the biological functions of viral m6A methylation are poorly understood. Here, we found that viral m6A methylation serves as a molecular marker for host innate immunity to discriminate self from nonself RNA and that this novel biological function of viral m6A methylation is universally conserved in several families in nonsegmented negative-sense (NNS) RNA viruses. Using m6A methyltransferase (METTL3) knockout cells, we produced m6A-deficient virion RNAs from the representative members of the families Pneumoviridae, Paramyxoviridae, and Rhabdoviridae and found that these m6A-deficient viral RNAs triggered significantly higher levels of type I interferon compared to the m6A-sufficient viral RNAs, in a RIG-I-dependent manner. Reconstitution of the RIG-I pathway revealed that m6A-deficient virion RNA induced higher expression of RIG-I, bound to RIG-I more efficiently, enhanced RIG-I ubiquitination, and facilitated RIG-I conformational rearrangement and oligomerization. Furthermore, the m6A binding protein YTHDF2 is essential for suppression of the type I interferon signaling pathway, including by virion RNA. Collectively, our results suggest that several families in NNS RNA viruses acquire m6A in viral RNA as a common strategy to evade host innate immunity.IMPORTANCE The nonsegmented negative-sense (NNS) RNA viruses share many common replication and gene expression strategies. There are no vaccines or antiviral drugs for many of these viruses. We found that representative members of the families Pneumoviridae, Paramyxoviridae, and Rhabdoviridae among the NNS RNA viruses acquire m6A methylation in their genome and antigenome as a means to escape recognition by host innate immunity via a RIG-I-dependent signaling pathway. Viral RNA lacking m6A methylation induces a significantly higher type I interferon response than m6A-sufficient viral RNA. In addition to uncovering m6A methylation as a common mechanism for many NNS RNA viruses to evade host innate immunity, this study discovered a novel strategy to enhance type I interferon responses, which may have important applications in vaccine development, as robust innate immunity will likely promote the subsequent adaptive immunity.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  N6-methyladenosine; innate immunity; negative-strand RNA virus

Year:  2021        PMID: 33536170     DOI: 10.1128/JVI.01939-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  8 in total

1.  A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.

Authors:  Mijia Lu; Yuexiu Zhang; Piyush Dravid; Anzhong Li; Cong Zeng; Mahesh Kc; Sheetal Trivedi; Himanshu Sharma; Supranee Chaiwatpongsakorn; Ashley Zani; Adam Kenney; Chuanxi Cai; Chengjin Ye; Xueya Liang; Jianming Qiu; Luis Martinez-Sobrido; Jacob S Yount; Prosper N Boyaka; Shan-Lu Liu; Mark E Peeples; Amit Kapoor; Jianrong Li
Journal:  J Virol       Date:  2021-08-11       Impact factor: 6.549

Review 2.  Regulation of Antiviral Immune Response by N 6-Methyladenosine of mRNA.

Authors:  Baoxin Zhao; Weijie Wang; Yan Zhao; Hongxiu Qiao; Zhiyun Gao; Xia Chuai
Journal:  Front Microbiol       Date:  2021-12-16       Impact factor: 5.640

3.  Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus.

Authors:  Miaoge Xue; Yuexiu Zhang; Haitao Wang; Elizabeth L Kairis; Mijia Lu; Sadeem Ahmad; Zayed Attia; Olivia Harder; Zijie Zhang; Jiangbo Wei; Phylip Chen; Youling Gao; Mark E Peeples; Amit Sharma; Prosper Boyaka; Chuan He; Sun Hur; Stefan Niewiesk; Jianrong Li
Journal:  PLoS Pathog       Date:  2021-12-20       Impact factor: 6.823

Review 4.  The Emerging Role of RNA Modifications in the Regulation of Antiviral Innate Immunity.

Authors:  Jie Tong; Wuchao Zhang; Yuran Chen; Qiaoling Yuan; Ning-Ning Qin; Guosheng Qu
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

5.  Global m6A RNA Methylation in SARS-CoV-2 Positive Nasopharyngeal Samples in a Mexican Population: A First Approximation Study.

Authors:  Jorge Luis Batista-Roche; Bruno Gómez-Gil; Gertrud Lund; César Alejandro Berlanga-Robles; Alejandra García-Gasca
Journal:  Epigenomes       Date:  2022-06-29

Review 6.  The Impact of Epitranscriptomics on Antiviral Innate Immunity.

Authors:  Beril Mersinoglu; Sara Cristinelli; Angela Ciuffi
Journal:  Viruses       Date:  2022-07-28       Impact factor: 5.818

7.  m6A mRNA Methylation Regulates Epithelial Innate Antimicrobial Defense Against Cryptosporidial Infection.

Authors:  Zijie Xia; Jihao Xu; Eugene Lu; Wei He; Silu Deng; Ai-Yu Gong; Juliane Strass-Soukup; Gislaine A Martins; Guoqing Lu; Xian-Ming Chen
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

Review 8.  Post-Transcriptional Regulation of Viral RNA through Epitranscriptional Modification.

Authors:  David G Courtney
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.